Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced that European Urology Oncology published results of a clinical study demonstrating ...

A diagnosis of adenocarcinoma of the bladder requires careful and specialized care. Because it is rare, it is essential to be treated by a multidisciplinary team, including a urologic oncologist, ...

White-light cystoscopy is the main method of detecting transitional cell carcinoma of the bladder. Flat carcinoma in situ (CIS) lesions can, however, be difficult to detect with this technique. Fradet ...

Xu, W. , Xing, X. and Cheng, S. (2025) Urine-Based Liquid Biopsy for Detecting Recurrence of Bladder Cancer. International ...

SAN DIEGO & REHOVOT, Israel--(BUSINESS WIRE)--Nucleix, a liquid biopsy company revolutionizing cancer treatment by detecting the disease earlier, today announced the publication of an analysis ...

Blue light cystoscopy reduces bladder cancer recurrence risk by 38% compared to white light cystoscopy, as shown in the BRAVO study. The BRAVO study used real-world data from 626 veterans, confirming ...

Decades ago, blue lights helped shoppers scope out sales. Today they’re helping urologists scope out cells – specifically those of non-muscle-invasive bladder cancer. UW Medicine urologists with ...

AUREA study: Atezolizumab (Atezo) combined with split-dose gemcitabine plus cisplatin (s-GC) in locally advanced or metastatic urothelial cancer (LA/mUC): A SOGUG study. Background: Patients [pts] ...

There are different stages of bladder cancer depending on how the tumor has spread. The staging of bladder cancer can help a medical professional map out the best treatment plan and improve a person’s ...

"With its potential for screening, recurrence monitoring, treatment guidance, and prognosis prediction, utDNA is poised to transform bladder cancer management and personalize patient care." — Liang ...